Tonix Pharmaceuticals Holding Corp at Raymond James Human Health Innovation Conference (Virtual) Transcript
Good morning and welcome to the third day of the 2021 Raymond James Human Health Innovation Conference. My name is Matthew Karpf with Raymond James investment banking. I'm very lucky to be joined by Seth Lederman, Co-Founder, CEO, and Chairman of Tonix Pharmaceuticals. (Conference Instructions). Seth, handing it off to you.
Thank you very much, and thanks to the organizers for having us and thanks to everyone who is participating. I'm Seth Lederman, CEO of Tonix Pharmaceuticals. And I'd like to take you through our presentation this morning. (technical difficulty)
Tonix is on NASDAQ, our ticker is TNXP; and it is a very exciting time for Tonix. So, it's a good time, if you haven't been following us, to start watching. This is our standard Safe Harbor statement. We'll be making forward-looking statements and I refer you to our SEC documents, the 10-K and other documents for more complete information.
Tonix is a NASDAQ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |